Maternus-Kliniken AG buy krebskrebs
Start price
27.06.23
/
50%
€1.37
Target price
27.06.24
€1.65
Performance (%)
27.01%
End price
28.06.24
€1.74
Summary
This prediction ended on 28.06.24 with a price of €1.74. The prediction had a final performance of 27.01%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Maternus-Kliniken AG | -10.345% | -10.345% | -21.805% |
| iShares Core DAX® | 4.852% | -4.418% | 13.097% |
| iShares Nasdaq 100 | 3.999% | -3.283% | 31.335% |
| iShares Nikkei 225® | 4.221% | -6.223% | 44.472% |
| iShares S&P 500 | 3.324% | -3.174% | 24.360% |
Comments by krebskrebs for this prediction
In the thread Maternus-Kliniken AG diskutieren
Buy mit Kursziel 1,65
In the thread Trading Maternus-Kliniken AG
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

